Merck & Co., Inc. Sees Increased Institutional Investment
Mitsubishi UFJ Asset Management Co. Ltd. has increased its stake in Merck & Co., Inc. (NYSE:MRK) by 7% during the second quarter, according to the company's most recent 13F filing with the Securities and Exchange Commission.
The firm now owns approximately 6.18 million shares of Merck & Co., Inc.'s stock, valued at $794.58 million as of its latest SEC filing.
This is not an isolated instance, as other institutional investors have also been buying into Merck & Co., Inc. recently. State Street Corp has raised its position in the company by 1.6% during the fourth quarter, while Wellington Management Group LLP increased its stake in shares of Merck & Co., Inc. by 14.8%.
Despite these increases, some analysts have expressed caution regarding the company's growth prospects. A recent report noted that the cancer-vaccine opportunity remains early and that potential barriers include manufacturing complexity, cost, patient selection, and regulatory review and broader clinical validation.